Fatal pulmonary aspiration of oral activated charcoal
Oral activated charcoal is used to limit drug absorption after overdose, and repeated administration may enhance the removal of drugs already absorbed.' 2 Such treatment is normally considered to be safe, and little information is available about complications. We report a case offatal respiratory failure after pulmonary aspiration of oral activated charcoal.
Case report A 58 year old man with a long history of epilepsy, disturbed behaviour, depression, and admissions for self poisoning was found unrousable. He took phenobarbitone, carbamazepine, and clonazepam regularly and was presumed to have taken an overdose. On examination his temperature was 33°C, pulse rate 60 beats/minute, and blood pressure 110/60 mm hg, and his chest was clear. Response to stimulation was minimal, the gag reflex was present, and there were no focal neurological signs. The arterial oxygen and carbon dioxide tensions while he was breathing 30% oxygen were 17 8 and 5 5 kPa respectively. A chest x ray film and an electrocardiogram were normal. Plasma concentrations of phenobarbitone and carbamazepine were reported as >220 imol/I (>50 mg/l) and 81 ,umol/l (19 mg/l) respectively.
Gastric lavage was performed. Unfortunately, the molar units in which the phenobarbitone concentration was reported were misinterpreted and a standard regimen of forced alkaline diuresis was started and activated charcoal (Medicoal) administered by nasogastric tube. The position of the tube was checked by aspiration of gastric acid, the head of the bed was raised, and a loading dose of 50 g charcoal in 200 ml water was given. Subsequently, further doses of 12 5 g charcoal were administered hourly after aspiration of the stomach contents. Vomiting occurred 12 hours later with pulmonary aspiration of gastric contents. The trachea was intubated and charcoal suctioned out of the upper airways. With the airway protected further charcoal was given through the nasogastric tube. Chest physiotherapy was given and intravenous flucloxacillin and metronidazole started. His condition improved, and at 48 hours he was alert and orientated.
Over the next 24 hours fever and tachycardia developed, and his arterial oxygen and carbon dioxide tensions were 7-7 kPa and 5-3 kPa respectively while he was breathing 40% oxygen. A chest x ray film showed generalised bilateral opacities (figure), and lung function deteriorated progressively. Assisted ventilation was started on day 8 but was withdrawn five days later after he suffered a major stroke. The neurological deficit and severe respiratory impairment persisted, and chest x ray films showed severe abnormalities; he died 15 days after admission. lobe consolidation, but sputum cultures were negative. Appearances at bronchoscopy were normal, and transbronchial biopsy specimens showed an interstitial pneumonitis. Seven days after bronchoscopy he was readmitted to hospital with severe headache, photophobia, a fever of 38-5°C, and severe neck stiffness. The peripheral white cell count was 16 8 x 1IO/l (89% polymorphs), and lumbar puncture yielded a purulent cerebrospinal fluid containing 2750x 109 polymorphonuclear leucocytes per litre: protein concentration was raised at 1-6 g/l and glucose reduced at 2-1 mmol/l (blood glucose 8-2 mmol/l). No organisms were seen on Gram, auramine, or Ziehl-Neelson staining. Latex coagglutination testing (Inverclyde Biologicals) of the cerebrospinal fluid was negative for pneumococcal capsular antigen, cultures of cerebrospinal fluid and blood remained sterile, and serological testing for viruses and Mycoplasma pneumoniae gave negative results.
He was given ampicillin and chloramphenicol for 14 days and antituberculous treatment (rifampicin, pyrazinamide, and isoniazid) for the first six days. A repeat lumbar puncture after seven days showed a fall in the polymorphonuclear count to 1020x 109/l. He developed a transient right facial palsy. Serial computed tomograms showed the development of an area of infarction in the right parietal region. A repeat chest radiograph showed resolution of the original consolidation. He made a partial recovery, but three months later, having returned to the care of his general practitioner, he remained disorientated, ataxic, and incontinent. Serological tests at this stage, arranged by his general practitioner, showed IgM antibodies to Borrelia burgdorferi at a titre of 1/512 by indirect immunofluorescence. Retrospective examination of serum obtained at the time of his acute meningitis gave negative results, while serum taken five months later showed IgG but not IgM antibody at a titre of 1/256, indicating a recent infection occurring around the time of the meningitis. He was negative for antinuclear antibodies, rheumatoid factor, and leptospira antibodies, and gave negative results to Treponema pallidum haemagglutination and Venereal Disease Research Laboratory tests. Six months after the initial presentation, when he had almost fully recovered, he developed a peripheral neuritis with a right foot drop, which improved after treatment with intravenous benzylpenicillin 12 MU daily for two weeks. He recalled having had several tick bites while working on his farm but gave no history of a rash or arth.ropathy.
Comment
Our patient probably had Lyme disease complicated by acute pyogenic meningitis, though this has not been described before. He had the classic triad of neurological manifestations-meningitis, cranial neuritis, and late peripheral neuritis'-and his serological findings were consistent with recent infection by B burgdorferi. Other known causes of serological cross reactivity such as syphilis and leptospirosis were excluded. ' We do not know why this patient responded to infection with B burgdorferi with acute pyogenic meningitis, cerebral infarction suggestive of an associated vasculitis, and possibly pneumonitis. The virulence of the infecting organism may be relevant. North American and European strains of B burgdorferi differ in their major proteins so we may expect to see differences between the disease in the United States and Britain.5 Erythema chronicum migrans and arthropathy are less common in European than in American cases.' At this stage in our knowledge of Lyme disease in Britain we would draw attention by this report to unusual presentations of the disease, which may reflect differences from the syndrome originally described in Connecticut.
